Javier Zambrano

Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE)

Edward Fox, Alberto Vásquez, William Grainger et al. · International Journal of MS Care · 2015 · 50 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Challenges and Opportunities in IBD Clinical Trial Design

Marla C. Dubinsky, Rory Collins, María T. Abreu et al. · Gastroenterology · 2021 · 32 citations · Full text

Medicine, Internal Medicine, Clinical Pharmacology +8

Subcutaneous Peginterferon β-1a injection-site Reaction Experience and Mitigation: Delphi Analysis of the Allow Study

Barry Hendin, DeRen Huang, Sibyl Wray et al. · Neurodegenerative Disease Management · 2017 · 18 citations · Full text

Life Sciences, Clinical Sciences, Neurology +16

Strategies for Successful Long-Term Engagement of Adults With Phenylalanine Hydroxylase Deficiency Returning to the Clinic

Janet A. Thomas, Mina Nguyen‐Driver, Heather Bausell et al. · Journal of Inborn Errors of Metabolism and Screening · 2017 · 14 citations · Full text

Medicine, Internal Medicine, Clinical Medicine +11

Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn’s Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies

Jean‐Frédéric Colombel, Stefan Schreiber, Geert D’Haens et al. · Journal of Crohn s and Colitis · 2023 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17